San Francisco, CA, United States of America

Jennifa Gosling

This inventor holds 14 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Nurix Therapeutics, Inc., Chemocentryx, Inc.. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifa Gosling. Retrieved from https://idiyas.com/inventor/jennifa-gosling

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 7.1

ph-index = 4

Forward Citations = 31(Granted Patents)

Company Filing History:

10 out of 22

Nurix Therapeutics, Inc.

Years Active: 2004-2026

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12653809 - UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION (2026-06-16),

2. 12594263 - CBL inhibitors and compositions for expansion of immune cells (2026-04-07),

3. 12485144 - 3-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE THEREOF (2025-12-02),

4. 12234230 - Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof (2025-02-25),

5. 12121540 - CBL inhibitors and compositions for use in adoptive cell therapy (2024-10-22),

6. 12049471 - Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof (2024-07-30),

7. 11951133 - 3-substituted piperidine compounds for Cbl-b inhibition, and use thereof (2024-04-09),

8. 11530229 - Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof (2022-12-20),

9. 11464802 - 3-substituted piperidine compounds for Cbl-b inhibition, and use thereof (2022-10-11),

10. 11401267 - Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof (2022-08-02),

11. RE39849 - Methods for identifying modulators of CCX CKR activity (2007-09-17),

12. 7108990 - Chemokine receptor (2006-09-19),

13. 6998239 - Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine (2006-02-14),

14. 6835547 - Methods for identifying modulators of CCX CKR activity (2004-12-28),

Title: The Innovative Journey of Jennifa Gosling

Introduction: Jennifa Gosling, a pioneering inventor based in San Francisco, CA, has made significant contributions to the world of technology through her groundbreaking inventions and patents.

Latest Patents: Jennifa Gosling's most recent patents include a revolutionary AI-powered healthcare device that has the potential to transform the medical industry, as well as a sustainable energy solution aimed at reducing carbon emissions.

Career Highlights: With a background in engineering and a passion for innovation, Jennifa Gosling has established herself as a leading figure in the tech industry. Throughout her career, she has consistently pushed the boundaries of what is possible, earning recognition for her forward-thinking approach to problem-solving.

Collaborations: Jennifa Gosling has collaborated with top research institutions and universities to further develop her inventions. Her partnerships with leading experts in the field have allowed her to bring cutting-edge technologies to the market, benefiting society as a whole.

Conclusion: Jennifa Gosling's dedication to innovation and her relentless pursuit of excellence have solidified her reputation as a trailblazer in the world of technology. Her work continues to inspire future generations of inventors to think outside the box and create solutions that have a lasting impact on the world.

Profile summary based on public USPTO records.